1 option
Nitisinone (MDK-nitisinone) : (MendeliKABS inc.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine / Canadian Agency for Drugs and Technologies in Health, issuing body.
- Format:
- Book
- Series:
- Common drug review clinical review report.
- CADTH common drug review
- Language:
- English
- Subjects (All):
- Enzyme inhibitors.
- Amino acids--Metabolism--Disorders.
- Amino acids.
- Outcome assessment (Medical care).
- Physical Description:
- 1 online resource (57 pages) : illustrations.
- Other Title:
- Nitisinone
- Place of Publication:
- Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, [2018]
- Notes:
- Description based on: online resource; title from PDF title page (NCBI, viewed October 29, 2022).
- Includes bibliographical references.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.